Literature DB >> 21605257

Linear morphea-induced atrophy treated with hyaluronic acid filler injections.

Adrienne N Choksi1, Jeffrey S Orringer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21605257     DOI： 10.1111/j.1524-4725.2011.02030..x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN： 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  8 in total

1.  Update on management of connective tissue panniculitides.

Authors:  Inbal Braunstein; Victoria P Werth
Journal:  Dermatol Ther       Date:  2012 Mar-Apr       Impact factor: 2.851

2.  Hyaluronic Acid Filler Injection for Localized Scleroderma - Case Report and Review of Literature on Filler Injections for Localized Scleroderma.

Authors:  Jaishree Sharad
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-11

Review 3.  Acquired facial lipoatrophy: pathogenesis and therapeutic options.

Authors:  Aneta Szczerkowska-Dobosz; Barbara Olszewska; Małgorzata Lemańska; Dorota Purzycka-Bohdan; Roman Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

4.  Persistence of hyaluronic Acid filler for subcutaneous atrophy in a case of circumscribed scleroderma.

Authors:  Shehnaz Z Arsiwala
Journal:  J Cutan Aesthet Surg       Date:  2015 Jan-Mar

5.  Treatment of Linear Morphea (en Coup de Sabre) with Micronized Acellular Dermal Matrix Filler: A Case Report.

Authors:  Jemin Kim; Jihee Kim; Young In Lee; Ju Hee Lee
Journal:  Ann Dermatol       Date:  2021-07-01       Impact factor: 1.444

6.  Implantation of autologous fat globules in localized scleroderma and idiopathic lipoatrophy--report of five patients.

Authors:  Tiago Pina Zanelato; Giovana Marquesini; Paula Tavares Colpas; Renata Ferreira Magalhães; Aparecida Machado de Moraes
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

7.  Scleroderma en coup de sabre treated with polymethylmethacrylate - Case report.

Authors:  Joanna Pimenta de Araujo Franco; Márcio Soares Serra; Ricardo Barbosa Lima; Antônio Macedo D'Acri; Carlos José Martins
Journal:  An Bras Dermatol       Date:  2016-04       Impact factor: 1.896

8.  Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study.

Authors:  Roberto Pirrello; Barbara Verro; Giulia Grasso; Piero Ruscitti; Adriana Cordova; Roberto Giacomelli; Francesco Ciccia; Giuliana Guggino
Journal:  Arthritis Res Ther       Date:  2019-12-13       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.